Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 27 results for "diovan hct"

Diovan generic may fetch Ranbaxy $150 mn revenue: Centrum

There are host of players which are already there with Diovan HCT, seven players are already there in the market with a combination, so upside for Ranbaxy will be limited, says Ranjit Kapadia of Centrum Broking Money Control, 2 months ago

Sandoz introduces high blood pressure tablets in US

Sandoz, the generic pharmaceutical division of Novartis, has introduced an authorized generic version of Diovan tablets for the treatment of high blood pressure, or HBP, in the US. This launch follows the Sandoz US introduction of an authorized ...
 Individual.com1 month ago

Novartis sales flag on Diovan generics, but CEO promises cost cuts will fuel profits

Novartis CEO Joe Jimenez Take a look at Novartis' ($NVS) second-quarter results for reasons why it engineered that big asset swap-and-sale with GlaxoSmithKline ($GSK) and Eli Lilly ($LLY). The two units Novartis is unloading, vaccines and animal ...
 FiercePharma1 month ago

50 Ways to Cut Your Health Care Costs

JewishWorldReview.com | No matter how you get your insurance -- through your employer, from a state exchange, from an agent or directly from an insurance company -- you're paying a bigger share of your health-care costs than you used to. Higher ...
 Jewish World Review2 weeks ago 31 Ways to Cut Your Health-Care Costs  Jewish World Review2 months ago

Top 100 Most Prescribed, Top-Selling Drugs

There has been little change in top-prescribed and top-selling prescription drugs in the United States, according to the latest data from research firm IMS Health. Hypothyroid medication levothyroxine ( Synthroid , AbbVie) continues to be the ...
 Medscape3 weeks ago

Global anti-hypertensives market to record slight decline as forecast CAGR to fall by 0.9% during 2013 to 2020

The global anti-hypertensives market is expected to decline during the forecast period at a negative Compound Annual Growth Rate (CAGR) of 0.9% from $40 billion in 2013 to $37.6 billion in 2020, with growth expected from 2013 to 2017 at a CAGR of ...
 TransWorldNews1 month ago Antihypertensive Therapeutics in Major Developed Markets to 2020  companiesandmarkets.com1 month ago Antihypertensive Therapeutics Market Is Expected to Reach $37.6 Billion by 2020  Franklin Credit Management Corporation2 months ago Market Research Reports, Inc. (www.marketresearchreports.com): Antihypertensive Therapeutics Market is Expected to Reach $37.6 billion by 2020  BusinessWeek2 months ago
[x]  
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less